Cardiovascular Safety of Hydroxychloroquine–Azithromycin in 424 COVID-19 Patients

Cardiovascular Safety of Hydroxychloroquine–Azithromycin in 424 COVID-19 Patients

<i>Background and Objectives</i>: Hydroxychloroquine (HCQ) combined with azithromycin (AZM) has been widely administered to patients with COVID-19 despite scientific controversies. In particular, the potential of prolong cardiac repolarization when using this combination has been discuss...

Full description

Bibliographic Details
Main Authors: Matthieu Million, Jean-Christophe Lagier, Jérôme Hourdain, Frédéric Franceschi, Jean-Claude Deharo, Philippe Parola, Philippe Brouqui
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Medicina
Subjects:
COVID-19
SARS-CoV-2
hydroxychloroquine
azithromycin
QTc interval
cardiac rhythm
Online Access:https://www.mdpi.com/1648-9144/59/5/863

Internet

https://www.mdpi.com/1648-9144/59/5/863

Similar Items